INTRODUCTION {#s1}
============

The airway mucociliary escalator consists of secretory and multicilated cells and captures inhaled debris and particles for clearance. It is essential for respiratory health and changes in its cellular composition or function can cause respiratory conditions, including chronic infections which can lead to more serious, irreversible, airway disease such as bronchiectasis. Examples of disruptions to the mucociliary escalator are the emergence of excess mucous cells, or alterations in the amount or composition of mucous produced, which are features of many airway diseases including Cystic Fibrosis and Chronic Obstructive Pulmonary Disease. Similarly a decrease in the number of ciliated cells, or changes in ciliary beat frequency, are characteristics of Primary Ciliary Dyskinesia ([@BIO033944C13]; [@BIO033944C50]).

Multiciliated, also known as ciliated, cells are terminally-differentiated cells that in the steady-state adult mouse, basal cell-containing, airways (trachea and primary bronchi) are maintained by the division of the secretory cells ([@BIO033944C35]; [@BIO033944C38]; [@BIO033944C40], [@BIO033944C39]; [@BIO033944C55]). There is also evidence that ciliated cells can differentiate directly from basal cells *in vitro*, or following airway injury ([@BIO033944C3]; [@BIO033944C36]). Ciliated cells start to form in the mouse airway epithelium from about embryonic day (E) 15.5 ([@BIO033944C39]; [@BIO033944C51]) and their embryonic differentiation is known to require Notch inhibition ([@BIO033944C18]; [@BIO033944C31]; [@BIO033944C53]). Similarly, in the adult mouse trachea, Notch signalling is critical for the maintenance, and repair, of the mucociliary epithelium ([@BIO033944C23]; [@BIO033944C27]; [@BIO033944C37]; [@BIO033944C41]). FGFR1, Interleukin-6 (IL6), TGF-β and Wnt signalling have also all been implicated in controlling the relative numbers of adult airway secretory versus ciliated cells ([@BIO033944C2]; [@BIO033944C3]; [@BIO033944C10]; [@BIO033944C16]; [@BIO033944C25]; [@BIO033944C42]; [@BIO033944C46]), but the exact mechanisms by which these pathways interact to direct ciliogenesis are largely unclear.

Ciliated cell differentiation is increasingly well studied and is largely conserved between different mulitciliated epithelia in vertebrate species ([@BIO033944C43]). It has been separated into distinct phases: specification as a pre-multiciliated cell; amplification of centrioles; organisation and docking of centrioles (now termed basal bodies) at the apical membrane; and cilia outgrowth ([@BIO033944C5]). The most upstream transcriptional regulators of airway ciliated cell fate specification known are GemC1 (Geminin C1) and Mcin (Multicilin), and when these proteins are knocked down, or knocked out, ciliated cells are not specified ([@BIO033944C1]; [@BIO033944C45]; [@BIO033944C48]). GemC1 and Mcin regulate the transcription factor network that controls centriole amplification and basal body docking, which in the airways includes Chibby, E2F4, Foxj1, Myb, Rfx3, and Tp73 ([@BIO033944C4]; [@BIO033944C6]; [@BIO033944C7]; [@BIO033944C11]; [@BIO033944C26]; [@BIO033944C28]; [@BIO033944C30]; [@BIO033944C32]; [@BIO033944C34]; [@BIO033944C47]; [@BIO033944C56]). Grhl2 (Grainyhead-like 2) is also a transcription factor involved in ciliated cell differentiation, although this may be due to more fundamental roles in epithelial morphogenesis and apical-basal polarity ([@BIO033944C15], [@BIO033944C14]).

Multiple studies have identified ciliated cell-specific genes and direct targets of ciliated cell-specific transcription factors ([@BIO033944C8]; [@BIO033944C20]; [@BIO033944C22]; [@BIO033944C44]). However, the function of many of these genes in ciliogenesis has not yet been tested. We developed an embryonic mouse tracheal explant assay to test the ability of over-expressed genes to alter tracheal epithelial differentiation. Using this assay, we assessed the ability of candidate transcriptional regulators, identified in a microarray experiment, to promote ciliogenesis. *Fibronectin type 3 and ankyrin repeat domains 1* (*Fank1*) and *JAZF zinc finger 1* (*Jazf1*) could promote ciliated cell differentiation alone, or cooperatively with the canonical ciliated cell transcription factor Foxj1. Knock-down of *Fank1* or *Jazf1* in adult mouse airway epithelial cultures demonstrated that these factors are required for adult ciliated cell differentiation *in vitro*. Further *in vitro* analysis suggested that Fank1 and Jazf1 function upstream of Foxj1 expression, but are likely to be down-stream of IL6-signalling.

RESULTS {#s2}
=======

Multicilated cell transcriptome of the E17.5 mouse airways {#s2a}
----------------------------------------------------------

We reasoned that genes which promote differentiation of ciliated cells would be expressed highly in developing ciliated cells of the embryonic mouse airways. Airway progenitors begin to differentiate as ciliated cells from E15.5 onwards. We therefore isolated RNA from multipotent (tip) progenitors at E11.5 (before ciliated cell differentiation) and from *FOXJ1-GFP-*expressing ciliated cells at E17.5 (shortly after differentiation). We performed microarray analysis to compare these samples and generate a differentiating airway ciliated cell-specific transcriptome ([Fig. 1](#BIO033944F1){ref-type="fig"}A). Gene Ontology (GO) analysis confirmed that the *FOXJ1-GFP* transcriptome was enriched in ciliated cell-specific gene classes compared to the whole genome ([Fig. 1](#BIO033944F1){ref-type="fig"}B). To focus on genes that were predicted to function primarily in a cell autonomous fashion, we listed differentially expressed transcription factors, and a small number of genes which were annotated as nuclear-localised using cut-offs of fold-change \>3; average expression level \>5 arbitrary units ([Table S1](Table S1)). RNA *in situ* hybridisation for a subset of these genes showed that the majority (7/10 tested; *Foxj1*, *Mlf1*, *Tp73*, *Zcchc12*, *Dlx4*, *Hipk3*, *Hes6*) were expressed in a salt-and-pepper fashion in the E17.5 mouse airways, consistent with specific expression in ciliated cells. The remaining three transcripts tested (*Casz1*, *Nr4a3*, *Sox1*) were enriched in the airways ([Fig. 1](#BIO033944F1){ref-type="fig"}C). Fig. 1.**A ciliated cell-specific transcriptome for the developing mouse airways.** (A) Diagram illustrating the lineage relationships between cells in the embryonic lung. Rectangles denote cell populations isolated for microarray analysis. (B) GO analysis of transcripts enriched \>3-fold in the E17.5 *FOXJ1-GFP^+^* cells compared with the E11.5 tip progenitors showed that categories associated with cilia were highly enriched compared with their frequency in the reference genome. (C) mRNA *in situ* hybridisation for *Foxj1*, *Mlf1*, *Tp73*, *Zcchc12*, *Dlx4*, *Hipk3*, *Hes6*, *Nr4a3*, *Casz1* and *Sox1* in the E17.5 stage mouse airways. Scale bars: 100 μm; 50 μm in insets.

An *ex vivo* functional assay for factors that are sufficient to promote ciliated cell differentiation in the mouse embryonic trachea {#s2b}
-------------------------------------------------------------------------------------------------------------------------------------

We established a relatively simple method for testing the ability of selected nuclear factors to promote ciliated cell differentiation. We isolated E14.5 tracheae from outbred MF1 mice and confirmed that ciliated cell differentiation occurred reproducibly during 7 days of organ culture in Dulbecco\'s modified Eagle medium (DMEM)/F12 medium ([Fig. 2](#BIO033944F2){ref-type="fig"}A-C) ([@BIO033944C18]). We next electroporated tracheae with a plasmid containing GFP and the gene of interest driven from a ubiquitous cytomegalovirus (CMV)/chicken β-actin promoter ([@BIO033944C19]). Tracheae were cultured for 7 days, fixed, sectioned and immunostained for GFP and acetylated tubulin (ACT, to identify cilia). Electroporated cells were scored manually as ciliated (GFP^+^, ACT^+^), or non-ciliated (GFP^+^, ACT^−^) ([Fig. 2](#BIO033944F2){ref-type="fig"}D,E). Electroporation using negative control (GFP-only) plasmid resulted in 45±1.4% (mean±s.e.m.) GFP^+^ ciliated cells; *n*=14 independent experiments. To confirm that we could alter the extent of ciliated cell differentiation in this assay we electroporated plasmids containing the intracellular domain of Notch1 (*Notch1^ICD^*) which is known to inhibit ciliogenesis ([@BIO033944C18]; [@BIO033944C53]), or *Multicilin* (*Mcin*) which promotes ciliogenesis ([@BIO033944C45]). As expected, *Notch1^ICD^* decreased the percentage of GFP^+^ ciliated cells to 3% (*n*=1), whereas *Mcin* increased the percentage of GFP^+^ ciliated cells to 78±2% (*n*=3), validating the overexpression assay ([Fig. 2](#BIO033944F2){ref-type="fig"}F). Fig. 2.**An *ex vivo* embryonic airway overexpression assay identifies *Fank1* and *Jazf1* as novel factors that can promote ciliated cell differentiation.** (A-C) Frozen sections showing *in vitro* differentiation of E14.5 wild-type mouse tracheae over 7 days *ex vivo*. (A,B) Green=TRP63, progenitor cells; red=E-cadherin, lateral cell membranes. (C) Green=ACT, ciliated cells; red=SCGB1A1, club cells. (D) Diagram of overexpression assay. E14.5 undifferentiated tracheae are electroporated with expression constructs and cultured for 7 days. Right panel shows whole-mount image of trachea at culture day 7 stained for GFP (green) and E-cadherin (red) to illustrate the typical extent of electroporation. (E) Examples of sectioned electroporated tracheae at E14.5+7 days. Green=GFP, electroporated cells; red=ACT, cilia; blue=DAPI, nuclei. (F) Graph to show percentage of electroporated GFP^+^ cells that co-stain with ACT in each condition tested. Data are mean±s.e.m. \**P*\<0.05 for Student\'s *t*-test compared with GFP plasmid. ^\#^*P*\<0.05 for Student\'s *t*-test compared with *Foxj1* plasmid. Scale bars: 100 μm in A; 200 μm in B and E; 40 μm in D.

*Foxj1* has previously been reported to promote ciliated cell differentiation when overexpressed in developing the lung alveoli, or zebrafish floorplate ([@BIO033944C49]; [@BIO033944C57]), but not when overexpressed in adult airway epithelial cells grown *in vitro* ([@BIO033944C56]). Moreover, airway ciliated cells are specified in *Foxj1* mutants, but blocked in their differentiation process as their basal bodies do not dock at the apical membrane ([@BIO033944C17]; [@BIO033944C56]). Hence, *Foxj1* transcription is typically considered to be necessary for ciliated cell differentiation, but not sufficient to promote ciliated cell fate. However, in our organ culture overexpression assay, *Foxj1* significantly increased the percentage of GFP^+^ ciliated cells to 68±3.6% (*n*=5; *P*=0.00183; [Fig. 2](#BIO033944F2){ref-type="fig"}F). Similarly, *Rfx3* is reported to be necessary for multiciliated cell differentiation, but not sufficient to promote differentiation of additional ciliated cells when expressed in cultured human airway epithelial cells ([@BIO033944C11]; [@BIO033944C12]). Preliminary experiments with *Rfx3* overexpression also resulted in an increase in the percentage of GFP^+^ ciliated cells to 76% ([Table S2](Table S2)). These results suggest that the developmental assay that we have established is a sensitive tool for identifying factors which have a function in the process of ciliated cell differentiation and is not limited to only the most upstream factors.

We next assayed the ability of a range of ciliated cell-specific nuclear factors identified in our microarray experiments for their ability to promote ciliated cell differentiation when electroporated into *ex vivo* embryonic tracheae ([Fig. 2](#BIO033944F2){ref-type="fig"}F; [Table S2](Table S2)). We aimed to identify factors that could promote ciliated cell differentiation to a similar extent to *Foxj1*. Out of 12 factors tested, three promoted ciliated cell differentiation to greater than 60% of GFP^+^ cells. These were *Fank1* (69±1.3%; *n*=3; *P*=0.0000024), *Jazf1* (65±4.1%; *n*=3; *P*=0.034) and *Homeodomain interacting protein kinase 1* (*Hipk1*) (61±4%; *n*=2; *P*=0.039). By contrast, *Regulatory Factor X, 2* (*Rfx2*) (32±1.9%; *n*=3; *P*=0.001) and *SRY box containing gene 1* (*Sox1*) (31±3%; *n*=3; *P*=0.017) both significantly decreased the extent of ciliated cell differentiation. This decrease was particularly surprising for *Rfx2* as it has previously been reported to function as a ciliated cell-specific transcription factor acting in parallel to, or downstream of, *Foxj1* ([@BIO033944C12]). Interestingly, Rfx2 has been suggested to coordinate both ciliated cell differentiation and cellular intercalation ([@BIO033944C9]). Such functions may result in a different phenotypic outcome in our assay, although this remains to be tested. *Rfx2* and *Sox1* were not explored further in the current study.

Of the three factors that promoted ciliated cell fate we focused on *Fank1* and *Jazf1.* (The *Hipk1* cDNA was inconveniently large and did not electroporate efficiently in the assay.) *Fank1* and *Jazf1* promoted ciliated cell fate to a similar extent to *Foxj1* and we wondered if the three factors could act synergistically. We therefore electroporated the three factors together. A combination of *Fank1*, *Foxj1* and *Jazf1* together was able to promote ciliated cell differentiation to a greater extent than *Foxj1* alone (87±2.4%; *n*=3; *P*=0.0043 Student\'s *t*-test compared to *Foxj1* plasmid; [Fig. 2](#BIO033944F2){ref-type="fig"}F). Preliminary data suggested that pairwise combinations of any two out of three of these TFs had a lesser effect than all three TFs together ([Table S2](Table S2)), so this was not explored further. This co-expression result suggested that the three factors may act together, or in parallel, in the hierarchy of factors that control ciliated cell differentiation.

*Fank1* and *Jazf1* transcripts are enriched in adult ciliated cells {#s2c}
--------------------------------------------------------------------

We tested in which adult mouse tracheal epithelial cells *Fank1* and *Jazf1* are expressed by isolating basal, ciliated, and secretory cells by flow cytometry for quantitative reverse transcription polymerase chain reaction (qRT-PCR). We found that *Fank1* was exclusively expressed in ciliated cells, similarly to *Foxj1*. By contrast, *Jazf1* was enriched in adult ciliated cells, but was also expressed in secretory and basal cells ([Fig. 3](#BIO033944F3){ref-type="fig"}A). These data are consistent with recent reports in which *Fank1* was found to be expressed in differentiating airway ciliated cells *in vivo* and *in vitro*, and in zebrafish cells ectopically over-expressing *Foxj1a* ([@BIO033944C8]; [@BIO033944C20]; [@BIO033944C44]; [@BIO033944C52]). Similarly, *Jazf1* was identified in differentiating airway ciliated cells *in vitro* ([@BIO033944C20]). Fig. 3.***Fank1* and *Jazf1* are specifically expressed in adult mouse airway ciliated cells and their *in vitro* knock-down inhibits ciliated cell differentiation.** (A) Relative levels of *Foxj1*, *Fank1* and *Jazf1* normalised to *Abl1*, detected by qRT-PCR in freshly isolated adult mouse tracheal basal, ciliated and secretory cells. *N*=3 biological replicates. Data are mean±s.e.m. (B) Experimental set-up for MTEC ALI culture expression time-course. (C,C′) Relative levels of *Fank1*, *Jazf1*, *Mcin*, *Myb*, *Foxj1*, *Rfx3* and *Cetn2* during ALI differentiation. Values normalised to *Abl1* and the highest value set to 1. *N*=3 biological replicates. Data are mean±s.e.m. *P*-values are for one-way analysis of variance test for difference between groups. (D) Experimental set-up for lentiviral knock-down of *Fank1* or *Jazf1* in MTEC ALI cultures. (E) Representative whole-mount images of ALI cultures infected with control shRNA, *Fank1* shRNA construct 2 and *Jazf1* shRNA construct 4 lentiviral vectors. Green: GFP (infected cells); red: ACT (cilia); white: E-cadherin (lateral cell membranes); blue: Dapi (nuclei). Scale bar: 200 μm. (F) Quantitation of staining in E showing percentage of infected GFP^+^ cells that are ciliated. Data are mean±s.e.m. *P*-values are for Student\'s *t*-test compared to control. (G) Fold change in proportion of GFP^+^ ciliated cells compared to scrambled control following infection of lentiviral knock-down constructs. Data are mean±s.e.m. *P*-values are for Student\'s *t*-test compared to control. (H) Graphs to show fold change in mRNA levels of *Fank1* or *Jazf1* in GFP^+^ cells following control, *Fank1* or *Jazf1* knock-down. Data normalised to *Abl1* and the control set at 1. *N*=3 biological replicates. Data are mean±s.e.m.

We also determined when during ciliated cell differentiation *Fank1* and *Jazf1* are expressed. We took advantage of adult mouse tracheal epithelial cell (MTEC) cultures that were differentiated at air-liquid interface (ALI). In such cultures, ciliogenesis occurs progressively, allowing the temporal separation of the various stages of ciliogenesis ([@BIO033944C34]; [@BIO033944C47]; [@BIO033944C54]). As expected of an upstream regulator, *Mcin* transcripts peaked at culture day 9 and then decreased. By contrast, levels of *Myb*, *Foxj1* and *Rfx3*, which are involved in basal body production, and the basal body component, *Cetn2*, increased over the ALI culture period ([Fig. 3](#BIO033944F3){ref-type="fig"}B,C′). *Fank1* and *Jazf1* increased gradually during ALI culture, similar to *Foxj1* and *Rfx3*. Although, *Jazf1* was also initially expressed at a relatively high level at day 9, consistent with its expression in adult basal cells *in vivo* ([Fig. 3](#BIO033944F3){ref-type="fig"}B,C).

Knock-down of *Fank1* or *Jazf1* in adult mouse airway cell cultures decreases the proportion of ciliated cells {#s2d}
---------------------------------------------------------------------------------------------------------------

The effects of knocking down *Fank1* and *Jazf1* were tested in MTEC cultures differentiated at ALI. We set up MTEC cultures and infected them with lentivirus containing GFP and an shRNA against *Fank1* or *Jazf1* on culture day 2. Cells were confluent by day 7 and were moved to ALI differentiation conditions. Cells were harvested at day 28 as preliminary experiments had shown that the number of ciliated cells continued to increase to at least day 28 ([Fig. 3](#BIO033944F3){ref-type="fig"}D). We tested four shRNAs against each gene and for each gene found one shRNA that reproducibly caused a decrease in the percentage of GFP^+^ infected cells that were also ACT^+^, compared to a scrambled shRNA control ([Fig. 3](#BIO033944F3){ref-type="fig"}E,F; [Table S3](Table S3)). The number of ciliated cells at culture day 28 varied considerably from experiment to experiment, even in the absence of lentiviral infection, but not between wells within an experiment. We therefore normalised the knock-down data by calculating the fold change in the proportion of GFP^+^ cells that are ACT^+^ within each experiment ([Fig. 3](#BIO033944F3){ref-type="fig"}G). This revealed that two of the constructs resulted in statistically significant decreases in the proportion of ciliated cells: *Fank1* shRNA construct 2 resulted in 0.69±0.02 (proportion of GFP^+^ ciliated cells normalised to GFP-only lentivirus±s.e.m.); *n*=3 biological replicates; *P*=0.005. *Jazf1* shRNA construct 4 resulted in 0.48±0.05 GFP^+^ ciliated cells; *n*=3 biological replicates; *P*=0.01. GFP^+^ cells were isolated from infected cultures at day 16 and subjected to qRT-PCR for *Fank1* and *Jazf1.* This confirmed that *Fank1* and *Jazf1* were knocked down compared to the scrambled control ([Fig. 3](#BIO033944F3){ref-type="fig"}H). Interestingly, transcript levels of both genes were decreased in these single knock-downs. However, this is likely to be due to a decrease in the overall number of fully differentiated ciliated cells in the GFP^+^ population.

*Fank1* and *Jazf1* likely function upstream of Foxj1 and downstream of IL6 and Notch signalling in ciliated cell fate specification {#s2e}
------------------------------------------------------------------------------------------------------------------------------------

To preliminarily place *Fank1* and *Jazf1* in the ciliated cell differentiation hierarchy, we examined the expression levels of known ciliated-specific factors following knock-down. The relative mRNA levels of *Mcin*, *Foxj1*, *Myb*, *Rfx3* and *Spag6* were all decreased in knock-down GFP^+^ cells compared to control ([Fig. 4](#BIO033944F4){ref-type="fig"}A,B). These data confirm our result from manual counting, that the number of GFP^+^ ciliated cells is decreased in the knock-downs. We therefore investigated the possibility that the cultures contained arrested ciliated cells which had been specified, but were blocked in their differentiation. This situation would be analogous to *Foxj1* knock-out airways in which ciliated cells are specified and produce basal bodies, but these do not dock at the apical surface and cilia do not form ([@BIO033944C17]; [@BIO033944C56]). We stained cultures with antibodies against Foxj1, γ-tubulin and ACT to distinguish any cells that had nuclear Foxj1 and/or replicated centrosomes (defined by more than two γ-tubulin puncta), but had not made cilia (defined by apical ACT). The percentage of GFP^+^, Foxj1^+^ cells was decreased in both *Fank1* and *Jazf1* shRNA cultures to a similar extent to the decrease in the percentage of ACT^+^ cells ([Figs 3](#BIO033944F3){ref-type="fig"}G and [4](#BIO033944F4){ref-type="fig"}C-E; [Table S4](Table S4)). Moreover, we were unable to identify arrested ciliated cells that had multiple γ-tubulin puncta, but no ACT ([Fig. 4](#BIO033944F4){ref-type="fig"}C,D). We therefore conclude that *Fank1* and *Jazf1* may be required for the initiation, or maintenance, of ciliated cell fate upstream of Foxj1 expression. Alternatively, we cannot exclude that they are required for the survival of differentiating ciliated cells, although we saw no obvious regions of dead or dying cells in the cultures during the experiments. Fig. 4.**Levels of ciliated cell-specific genes are decreased in the *Fank1* and *Jazf1* knock-downs.** (A) Experimental set-up for lentiviral knock-down of *Fank1* or *Jazf1* in MTEC ALI cultures followed by isolation of GFP^+^ cells at day 16 (B), or fixation for immunostaining at day 28 (C-E). (B) Graphs to show fold change in mRNA levels of *Mcin*, *Foxj1*, *Myb*, *Rfx3* and *Spag6* following control, *Fank1* or *Jazf1* knock-down. Data normalised to *Abl1* and the control set at 1. *N*=3 biological replicates. Data are mean±s.e.m. (C,D) Representative antibody staining from culture day 28. (C) Upper panels: merged images. Bottom panels: Foxj1/γ-tubulin co-localisation only. Green: GFP (lentiviral-infected cells); red: Foxj1 (ciliated cells); white: γ-tubulin (centrosomes and basal bodies). (D) Upper panels: GFP/ACT co-localisation. Lower panels: GFP/γ-tubulin co-localisation. Green: GFP (lentiviral-infected cells); red: ACT (cilia); white: γ-tubulin (centrosomes and basal bodies). All γ-tubulin^+^ cells are also ACT^+^. (E) Quantification of Foxj1 staining in C showing percentage of GFP^+^ cells that are Foxj1^+^. *N*=3 biological replicates. Data are mean±s.e.m. *P*-values are for Student\'s *t*-test compared to control. Scale bars: 50 μm.

Interleukin-6 (IL6) signalling has been shown to promote ciliated cell differentiation from basal stem cells ([@BIO033944C46]) and we were able to replicate this result in our MTEC ALI cultures (compare [Fig. 3](#BIO033944F3){ref-type="fig"}E with [Fig. 5](#BIO033944F5){ref-type="fig"}B). By contrast, Notch signalling inhibits ciliated cell differentiation ([@BIO033944C18]; [@BIO033944C53]) and inhibiting Notch increases the proportion of ciliated cells in MTEC ALI cultures ([@BIO033944C29]) (compare [Fig. 3](#BIO033944F3){ref-type="fig"}E with [Fig. 5](#BIO033944F5){ref-type="fig"}C). We used MTEC ALI cultures to test if *Fank1* and *Jazf1* function downstream, or independently, of IL6 and Notch signalling ([Fig. 5](#BIO033944F5){ref-type="fig"}A). A significant decrease in the percentage of GFP^+^ ciliated cells still occurred when *Fank1* and *Jazf1* were knocked down in the presence of IL6 or DAPT ([Fig. 5](#BIO033944F5){ref-type="fig"}B-E; [Tables S5](Tables S5) [and S6](and S6)). However, the fold changes were less in the presence of IL6 than in the control, untreated, cultures ([Fig. 5](#BIO033944F5){ref-type="fig"}F; [Table S7](Table S7)). This partial suppression of the *Fank1* and *Jazf1* knock-down phenotypes by IL6 suggests that *Fank1* and *Jazf1* are transcribed (directly or indirectly) downstream of IL6 and that the increase in their transcription caused by IL6 was sufficient to overwhelm the effect of the shRNA knock-down. Therefore, *Fank1* and *Jazf1* likely function downstream of IL6 signalling in the process of ciliated cell differentiation. By contrast, the presence of DAPT did not cause a statistically significant suppression in the *Jazf1* phenotype ([Fig. 5](#BIO033944F5){ref-type="fig"}F). However, combining the *Fank1* knock-down with DAPT treatment resulted in a significantly greater decrease in the proportion of ciliated cells than *Fank1* knock-down alone ([Fig. 5](#BIO033944F5){ref-type="fig"}F). There may be a close relationship between Fank1 expression and Notch signalling which warrants future further investigation. Fig. 5.**Fank1 and Jazf1 function downstream of IL6 in ciliated cell differentiation.** (A) Experimental set-up for lentiviral knock-down of *Fank1* or *Jazf1* in MTEC ALI cultures followed by addition of IL6 or DAPT. (B) Representative antibody staining of culture day 28 in the presence of IL6. (C) Representative antibody staining of culture day 28 in the presence of DAPT. Green: GFP (lentiviral-infected cells); red: ACT (apical cilia); white: E-cadherin (lateral cell membranes). Scale bars: 50 μm. (D,E) Graphs show percentage of GFP^+^ ciliated cells in knock-down cultures in the presence of IL6, or DAPT. (F) Graph shows fold-change in proportion of GFP^+^ ciliated cells in shRNA only controls, or in the presence of IL6 or DAPT. *N*=3 biological replicates. Data are mean± s.e.m. *P*-values are for Student\'s *t*-test compared to control.

DISCUSSION {#s3}
==========

We show that *Fank1* and *Jazf1* are sufficient to promote ciliated cell differentiation in mouse embryonic tracheal explant cultures and are necessary for ciliated cell differentiation in primary adult airway epithelial cultures. Moreover, our knock-down experiments suggest that these factors both act downstream of IL6 signalling, but upstream of Foxj1 expression.

Fank1 and Jazf1 have both previously been linked to ciliated cell differentiation in the mouse lung and in other systems. Both genes have been detected in *FOXJ1-GFP*-expressing differentiating ciliated cells in adult mouse airway cultures ([@BIO033944C20]). In embryonic mouse airways, *Fank1* has been identified as a putative marker of differentiating ciliated cells ([@BIO033944C52]) and as a putative *Foxj1* target ([@BIO033944C44]). Fank1 has also been identified as a direct target of Rfx2 in the *Xenopus* epidermis ([@BIO033944C9]) and a putative Foxj1a target in zebrafish ([@BIO033944C8]). To our knowledge, functional analysis of *Fank1* has not previously been carried out. There is only one report of *Jazf1* transcription in ciliated cells ([@BIO033944C20]), which is possibly explained by its transcription in non-ciliated airway epithelial cells and therefore lower fold change in genome-wide analyses. However, knock-down of a Zebrafish Jazf1 homologue, *Seson*, resulted in cilia phenotypes, including left-right patterning defects ([@BIO033944C21]).

Taken together, our data and the published reports suggest that *Fank1* and *Jazf1* are a conserved part of the cell autonomous multiciliogenesis differentiation process. It will be interesting in the future to further investigate their functions using mouse knock-outs and genetic manipulations in other species.

MATERIALS AND METHODS {#s4}
=====================

Mice {#s4a}
----

Wild-type MF1 outbred embryos were used for E14.5 tracheal cultures. Noon on the day of the plug was considered to be E0.5. Wild-type C57Bl/6J inbred mice (\>8 weeks old) were used for MTEC cultures. Mouse strain *FOXJ1-GFP* has been described previously ([@BIO033944C33]). All animal experiments were regulated under the Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following ethical review by the University of Cambridge Animal Welfare and Ethical Review Body (AWERB) (license numbers PPL70/812 and 70/7874).

E14.5 tracheal explant culture and electroporation {#s4b}
--------------------------------------------------

Ciliated cell-specific transcription factors were cloned into the Gateway-modified pCIG2 expression vector ([@BIO033944C19]). The pCIG2 vector contains a CMV/chicken β actin promoter which drives the gene of interest together with IRES-eGFP. Undifferentiated E14.5 mouse trachea and lungs were excised and placed in sterile DMEM/F12 medium (ThermoFisher Scientific, 11320-033) on ice. A fine glass capillary was used to microinject a plasmid solution (at least 2 mg/ml in sterile water, mixed with 0.04% Trypan Blue) into the trachea. The trachea were then immediately electroporated using an Electro Square Porator (Model ECM 830, BTX, Holliston, MA, USA) with 3×50 V, 50 ms pulses at 500 ms intervals. The lungs were dissected off and the electoporated tracheae were incubated floating in DMEM/F12 medium at 37°C, 5% CO~2~ for 7 days. During this period, differentiation took place. Medium was changed every 48 h. Each biological replicate consisted of at least four MF1 tracheae from a single litter.

MTEC ALI cultures {#s4c}
-----------------

Tracheae were cut into small pieces and incubated in 50% Dispase II (Gibco, 16 U/ml). Epithelial sheets were isolated and dissociated to single cells. Unless otherwise stated, 2×10^5^ cells in 0.25 ml of PneumaCult™ Expansion medium (Stem Cell Technologies, Vancouver, Canada, 05008) were plated on collagen-coated 24-well tissue culture inserts (BD Falcon, Corning, Tewksbury, MA, USA, 353180). Differentiation was induced in confluent cultures (usually 7 days post-plating) by removal of insert medium and addition of PneumaCult™ ALI medium (Stem Cell Technologies, 05001) to the outer chamber. The length of ALI culture ranged from 9 to 21 days as stated.

Lentiviral transduction of MTECs was performed on day 2 post-plating by adding 5 μl of concentrated lentivirus to 150 μl of fresh culture medium (transwell insert only) and incubating at 37°C overnight. The medium was changed the following morning.

Recombinant mouse IL6 (R&D Systems Europe, 406-ML-005) was used at 10 ng/ml throughout the ALI phase of culture and refreshed every 2 days at medium change. DAPT (Sigma-Aldrich, D5942) was used at 1 μM for 72 h from ALI day 1 to ALI day 4.

Lentiviruses {#s4d}
------------

Constructs containing GFP and a single shRNA against *Fank1* or *Jazf1* were obtained from GeneCopoeia™; LVRU6GP. Packaging and envelope plasmids used were pRSV-Rev (Addgene, 12253), pMDLg/pRRE (Addgene, 12251) and pMD2.G (Addgene 12259). Fugene™ (Promega, E2311) was used to transfect 70-80% confluent Lenti-X 293T cells with lentiviral constructs and packaging plasmids. Lentiviral-containing supernatant was collected on day 3, filtered at 0.45 μm and concentrated using PEG-it™ viral precipitation solution (System Biosciences, Paolo Alto, CA, USA, LV810A) according to the manufacturer\'s instructions. Aliquots of lentivirus were stored at −80°C until use. shRNA target sequences are listed in [Table S8](Table S8).

Antibody staining {#s4e}
-----------------

Cultured embryonic trachea were fixed 1 h at 4°C in 4% paraformaldehyde in PBS (4% PFA), sucrose protected and embedded in Optimal Cutting Temperature medium (OCT; Tissue Tek, Leiden, The Netherlands) before cryosectioning at 10 μm. Cells in 24-well transwell inserts were fixed in 4% PFA for 20 min at room temperature and stained whole mount with a 15 min 0.3% TritonX-100 permeabilisation step. Membranes were mounted in the centre of a SecureSeal™ image spacer (Sigma-Aldrich, GBL654006). Mounting medium was Fluoromount (Sigma-Aldrich).

Primary antibodies: mouse anti-acetylated tubulin (1:3000, Sigma-Aldrich, clone 6-11B-1); rat anti-E-cadherin (1:3000, Invitrogen, clone ECCD-2); mouse anti-Foxj1 (1:300, BD Bioscience, clone 2A5); rabbit anti-γ-tubulin (1:1000, Sigma-Aldrich, clone 310381); chick anti-GFP (1:1000, Abcam ab13970); mouse anti-p63 (1:500, Santa Cruz Biotechnology, clone 4A4); rabbit anti-Scgb1a1 (1:500; Santa Cruz Biotechnology, sc-25555). Antigen retrieval was in 10 mM boiling sodium citrate buffer pH6 for Foxj1 and p63 on cryosections. Alexa Fluor-conjugated secondary antibodies (ThermoFisher Scientific) were used at 1:2000. DNA (Dapi, Sigma-Aldrich).

Image analysis {#s4f}
--------------

Slides were photographed on a Axiophot compound microscope (Zeiss, Oberkochen, Germany) and GFP^+^ cells were scored as ciliated, or not-ciliated, based on apical acetylated tubulin staining (cilia) in the ImageJ software (NIH). In cryosections, only GFP^+^ cells with clearly visible apical and basal surfaces were scored. When possible, at least 100 GFP^+^ cells were counted in each experiment. Statistics were calculated using a Student\'s two-tailed *t*-test with unequal variance.

mRNA *in situ* hybridisation {#s4g}
----------------------------

*In situ* plasmids for 27 of the transcription factors were obtained from the mouse BMAP cDNA collection (mouse Brain Molecular Anatomy Project, ThermoFisher Scientific). The identity of 13 of the plasmids was verified by sequencing. The sequence of the remaining 14 did not match the reference mRNA sequence and were not used. DIG-labelled probes (DIG RNA labelling Kit, Roche, 11175025910) were generated from the 13 sequence-verified constructs and *in situ* hybridisation performed. Results were obtained with 10 probes. Briefly, frozen sections of E17.5 lungs were hybridised overnight with DIG-labelled anti-sense mRNA transcripts (at a temperature of 58-65°C in a 50% formamide humidified chamber), washed in dilute salt solutions at the hybridsation temperature and visualised using Alkaline Phosphatase coupled anti-DIG (1:2000, Roche 12930023) and BCIP/NBT (Roche, 1383213).

Microarrays and bioinformatics {#s4h}
------------------------------

E17.5 ciliated cells were isolated by flow sorting GFP^+^ cells from *FOXJ1-GFP* mice. RNA was isolated using the Qiagen RNEasy Mini Kit, amplified and labelled using the Ovation RNA Amplification Kit V2 and FL-Ovation Biotin V2 (NuGEN, Integrated Sciences, Willoughby, NSW, Australia). Hybridisation was to Affymetrix mouse 430.2 microarray chips (five chips per condition). Data were analysed using the Bioconductor Package in R and raw data deposited in Gene Expression Omnibus (GEO) **(**[GSE111300](GSE111300)**)**. Gene Ontology analysis was performed using GOToolbox (<http://genome.crg.es/GOToolBox/>). The E11.5 tip microarray data have been previously published ([@BIO033944C24]) and the raw data are available at GEO ([GSE75860](GSE75860)).

qRT-PCR {#s4i}
-------

MTEC cultures in transwell inserts were harvested by trypsinisation. In some experiments GFP^+^ cells were specifically isolated using a fluorescence-activated cell sorting MoFlo flow cytometer (Beckman Coulter Life Sciences, Indianapolis, IN, USA). Primary tracheal epithelial cells were isolated as for MTECs and sorted using the MoFlo flow cytometer. Wild-type cells were gated as basal EpCAM, GSIβ4 lectin; secretory EpCAM, SSEA1; ciliated EpCAM, CD24 as previously described ([@BIO033944C2]).

Total RNA was extracted using Qiagen RNEasy Mini Kit and cDNA was synthesised using Superscript III reverse transcriptase (Life Technologies). Sybr Green JumpStart™ TaqReadyMix (Sigma-Aldrich, S9194-400RXN) was used for qRT-PCR on an Applied Biosystems 7300 Real Time PCR System (ThermoFisher Scientific). For ALI time-course in [Fig. 3](#BIO033944F3){ref-type="fig"}C, Primer sequences are listed in [Table S9](Table S9).
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